Main| Contact Us| BP Claims| Site Map
Ask Attorney Logo Call Ask Attorney
Home | Accidents | Diseases | Drugs & Devices | Medical Malpractice | Products Liability | Other | Pollutants |
Drugs & Devices > Zevalin

Zevalin was developed by the IDEC Pharmaceuticals, which is now part of Biogen Idec. It was the first radioimmunotherapy drug approved by the Food and Drug Administration (FDA) in 2002 to treat cancer. Zevalin is used in the treatment of some forms of non-Hodgkin’s lymphoma.

Hazards associated with Zevalin

A necessary part of treatment procedure using Zevalin is an infusion of another medication called rituxima. This infusion can sometimes cause an allergic reaction, which normally begins 30 minutes to 2 hours after the infusion. The usual symptoms of this allergic reaction are:

  • Heart attack
  • Ventricular fibrillation
  • Cardiogenic shock
  • Chest pain
  • Acute Respiratory Distress Syndrome (ARDS)
  • Pulmonary infiltrates
  • Hypotension (low blood pressure)
  • Bronchospasm
  • Hypoxia
  • Difficulty breathing
  • Swelling of the lips, tongue and face
  • Hives
  • Increased coughing
  • Closing of the throat

The FDA (Food and Drug Administration) added a black box warning, the highest level of warning, for potentially deadly infusion reactions linked to the Zevalin regimen.

People who have been injured by prescription drugs without knowing the dangers of the drug can file a lawsuit against the manufacturer of the drug and recover damages. Biogen Idec had revealed in 2005 that the drug had caused severe and sometimes fatal skin reactions and even death. Until then, this was unknown to the FDA, public, and health care providers. Patients who suffered these side effects or families of those who passed away due to these reactions can claim compensation from Biogen Idec.

Free initial consultation - If you or a loved one has suffered an injury, illness or death that seems to be associated with Zevalin, please fill out and submit the form at the right or contact us today at-1-800-780-2686

Breaking News

Free Case Review

  Abacavir |   ACE Inhibitors |   Advil |   Ambien |   Avandia |   Botox |   Celexa |   Chantix |   Cymbalta |   Cytotec |   Desmopressin |   Diabetes and Seroquel |   Dilantin |   Duragesic Patch |   Fentanyl |   Erythropoiesis-Stimulating Agents (ESAs) |   Fleet Enema |   Fosamax |   Gadolinium |   Gardasil |   Heart Attack and Avandia |   Heparin |   Hydroxycut |   Kugel Mesh Patch |   Levaquin |   Levitra |   Meridia |   Motrin |   Neurontin |   NuvaRing |   Ortho Evra Patch |   Oxycontin |   Paxil |   Paxil & Breast Cancer |   Prempro |   Prozac |   Raptiva |   Reglan |   ReNu Contact Solution |   Ritalin |   Renu MultiPlus Solution |   Serevent |   Seroquel |   Shoulder Surgery and Pain Pump |   Singulair |   Tequin |   Tiazac |   Trasylol |   Viagra |   Vytorin |   Wellbutrin |   Xenadrine RFA-1 |   Xigris |   Xolair |   Yaz |   Zelnorm |   Zevalin |   Zicam |   Zithromax |   Zoloft |   Zometa |   Zyprexa | Call Now (800) 780-2686

Home| Accidents| Diseases| Drugs & Devices| Medical Malpractice| Products Liability| Other| Pollutants| Conatct Us | Site Map